soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm ADA 2025: Demonstrates Benefits in SOUL: Oral Semaglutide Bests Usual

How does oral semaglutide affect gastrointestinal function in patients with existing GI conditions

But their secondary use as a way for users to suppress diets and slim down sent sales through the roof

Just because two things happen at the same time does not mean one caused the other

Be sure to alert your cardiologist that you will be taking Wellbutrin as this could change your hypertension treatment as well

while prior centrally-acting drugs posed risks of mood disorders and cardiovascular consequences, the primary adverse effects of GLP-1 receptor agonists are gastrointestinal and often minor or temporary (Zheng et al